413 related articles for article (PubMed ID: 19562137)
21. Solubilization of ibuprofen with β-cyclodextrin derivatives: energetic and structural studies.
di Cagno M; Stein PC; Skalko-Basnet N; Brandl M; Bauer-Brandl A
J Pharm Biomed Anal; 2011 Jun; 55(3):446-51. PubMed ID: 21411261
[TBL] [Abstract][Full Text] [Related]
22. Affinity capillary electrophoresis and isothermal titration calorimetry for the determination of fatty acid binding with beta-cyclodextrin.
Parker KM; Stalcup AM
J Chromatogr A; 2008 Sep; 1204(2):171-82. PubMed ID: 18328491
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of bridged and metallobridged bis(beta-cyclodextrin)s containing fluorescent oxamidobisbenzoyl linkers and their selective binding towards bile salts.
Liu Y; Yu HM; Chen Y; Zhao YL
Chemistry; 2006 May; 12(14):3858-68. PubMed ID: 16514688
[TBL] [Abstract][Full Text] [Related]
24. Selective binding of steroids by 2,2'-biquinoline-4,4'-dicarboxamide-bridged bis(beta-cyclodextrin): fluorescence enhancement by guest inclusion.
Liu Y; Song Y; Wang H; Zhang HY; Wada T; Inoue Y
J Org Chem; 2003 May; 68(9):3687-90. PubMed ID: 12713379
[TBL] [Abstract][Full Text] [Related]
25. Interaction of bile salts with calcium hydroxyapatite: inhibitors of apatite formation exhibit high-affinity premicellar binding.
Qiu SM; Soloway RD; Crowther RS
Hepatology; 1992 Nov; 16(5):1280-9. PubMed ID: 1330869
[TBL] [Abstract][Full Text] [Related]
26. Displacement of Drugs From Cyclodextrin Complexes by Bile Salts: A Suggestion of an Intestinal Drug-Solubilizing Capacity From an In Vitro Model.
Olesen NE; Westh P; Holm R
J Pharm Sci; 2016 Sep; 105(9):2640-2647. PubMed ID: 26502027
[TBL] [Abstract][Full Text] [Related]
27. Novel pharmaceutical composition of bradykinin potentiating penta peptide with beta-cyclodextrin: physical-chemical characterization and anti-hypertensive evaluation.
Denadai AM; Ianzer D; Alcântara AF; Santoro MM; Santos CF; Lula IS; de Camargo AC; Faljoni-Alario A; dos Santos RA; Sinisterra RD
Int J Pharm; 2007 May; 336(1):90-8. PubMed ID: 17196774
[TBL] [Abstract][Full Text] [Related]
28. Structure and intramolecular flexibility of beta-cyclodextrin complex with (-)-epigallocatechin gallate in aqueous solvent.
Ishizu T; Hirata C; Yamamoto H; Harano K
Magn Reson Chem; 2006 Aug; 44(8):776-83. PubMed ID: 16705621
[TBL] [Abstract][Full Text] [Related]
29. Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5.
Létourneau D; Lorin A; Lefebvre A; Cabana J; Lavigne P; LeHoux JG
Biochim Biophys Acta; 2013 Nov; 1831(11):1589-99. PubMed ID: 23872533
[TBL] [Abstract][Full Text] [Related]
30. Molecular modeling study of beta-cyclodextrin complexes with (+)-catechin and (-)-epicatechin.
Yan C; Xiu Z; Li X; Hao C
J Mol Graph Model; 2007 Sep; 26(2):420-8. PubMed ID: 17320441
[TBL] [Abstract][Full Text] [Related]
31. Homodimerization and heteroassociation of 6-O-(2-sulfonato-6-naphthyl)-gamma-cyclodextrin and 6-deoxy-(pyrene-1-carboxamido)-beta-cyclodextrin.
Park JW; Song HE; Lee SY
J Org Chem; 2003 Sep; 68(18):7071-6. PubMed ID: 12946151
[TBL] [Abstract][Full Text] [Related]
32. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
Lane ME; O'driscoll CM; Corrigan OI
J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
[TBL] [Abstract][Full Text] [Related]
33. Hepatic transport of bile acid and effect of conjugation.
Kitani K
Ital J Gastroenterol; 1995 Jun; 27(5):270-6. PubMed ID: 8541581
[TBL] [Abstract][Full Text] [Related]
34. Stereoselective interaction of ketoprofen enantiomers with β-cyclodextrin: ground state binding and photochemistry.
Marconi G; Mezzina E; Manet I; Manoli F; Zambelli B; Monti S
Photochem Photobiol Sci; 2011 Jan; 10(1):48-59. PubMed ID: 20978661
[TBL] [Abstract][Full Text] [Related]
35. Inclusion complex of fenbufen with beta-cyclodextrin.
Bratu I; Gavira-Vallejo JM; Hernanz A; Bogdan M; Bora G
Biopolymers; 2004 Mar; 73(4):451-6. PubMed ID: 14991662
[TBL] [Abstract][Full Text] [Related]
36. Influence of the separation of the charged groups and aromatic ring on interaction of tyrosine and phenylalanine analogues and derivatives with beta-cyclodextrin.
Mrozek J; Banecki B; Karolczak J; Wiczk W
Biophys Chem; 2005 Aug; 116(3):237-50. PubMed ID: 15896899
[TBL] [Abstract][Full Text] [Related]
37. Phase behavior study of amphiphilic drugs: effect of pharmaceutical excipients.
Naqvi AZ; Rub MA; Kabir-ud-Din
Colloids Surf B Biointerfaces; 2012 Jun; 95():30-41. PubMed ID: 22429783
[TBL] [Abstract][Full Text] [Related]
38. Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.
Béni S; Szakács Z; Csernák O; Barcza L; Noszál B
Eur J Pharm Sci; 2007 Feb; 30(2):167-74. PubMed ID: 17145172
[TBL] [Abstract][Full Text] [Related]
39. Hydrophobicity is the governing factor in the interaction of human serum albumin with bile salts.
Ghosh N; Mondal R; Mukherjee S
Langmuir; 2015 Jan; 31(3):1095-104. PubMed ID: 25549008
[TBL] [Abstract][Full Text] [Related]
40. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
Yang ZX; Chen Y; Liu Y
Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
